Skip to main content
. 2021 Jun 17;65(7):e00079-21. doi: 10.1128/AAC.00079-21

TABLE 1.

MIC values (μg/ml) of delafloxacin and comparator antimicrobials against rapidly growing mycobacteria isolatesa

Antimicrobial (CLSI intermediate breakpoint)b MIC of delafloxacin against (no. of isolates):
M. abscessus subsp. abscessus (16) M. abscessus subsp. massiliense (5) M. chelonae (11) M. immunogenum (5) M. fortuitumf (13) M. fortuitum (CIPS) (9) M. fortuitum (CIPR) (4) M. porcinum (7) M. senegalense (7) M. mucogenicum group (5) M. goodii (1)
DEL (NA)d
    MIC range ≥16 4 to >16 ≥16 8 to >16 0.001 to >16 0.001–0.5 2 to >16 0.12–1 0.25–1 0.03–0.12 0.06
    MIC50 >16 >16 >16 >16 0.25 0.12 2 0.25 0.5 0.12 NA
    MIC90 >16 >16 >16 >16 2 0.5 NA 1 1 0.12 NA
CIP (2)
    MIC range ≥4 0.5 to >4 0.5 to >4 ≤0.12–4 ≤0.12 to >4 0.12–1 4 to >4 ≤0.12–0.5 0.25–0.5 ≤0.12–2 ≤0.12
    MIC50 4 4 1 2 ≤0.12 ≤0.12 >4 ≤0.12 0.5 0.25 NA
    MIC90 >4 >4 4 4 >4 1 NA 0.5 0.5 2 NA
MXF (2)
    MIC range 4 to >16 2 to >16 1 to >8 1 to >8 ≤0.06–8 ≤0.06–0.25 ≤0.06–8 ≤0.06–0.25 ≤0.06–0.12 0.25–0.5 ≤0.06
    MIC50 8 8 2 1 0.12 ≤0.06 0.5 ≤0.06 0.12 0.25 NA
    MIC90 16 >16 4 4 1 0.25 NA 0.25 0.12 0.5 NA
AMK (32)
    MIC range 4 to >64 8–16 ≤2–64 4–16 ≤2–4 ≤2 ≤2–4 ≤2 ≤2 ≤2 ≤2
    MIC50 8 8 8 8 ≤2 ≤2 ≤2 ≤2 ≤2 ≤2 NA
    MIC90 16 16 32 16 ≤2 ≤2 NA ≤2 ≤2 ≤2 NA
FOX (32–64)
    MIC range 32–64 16–32 >64 >64 ≤16–64 ≤16–64 32–64 ≤16–32 ≤16 ≤16 32
    MIC50 32 32 >64 >64 32 32 64 ≤16 ≤16 ≤16 NA
    MIC90 64 32 >64 >64 64 64 NA 32 ≤16 ≤16 NA
SXT (NA)c
    MIC rangee 2/38 to >4/76 2/38–4/76 1/19–4/76 ≤0.5/9.5 to >4/76 ≤0.5/9.5–2/38 ≤0.5/9.5–2/38 ≤0.5/9.5–1/19 ≤0.5/9.5–2/38 ≤0.5/9.5–2/38 ≤0.5/9.5 ≤0.5/9.5
    MIC50 4/76 4/76 2/38 4/76 0.5–9.5 0.5–9.5 ≤0.5/9.5 1/19 1/19 ≤0.5/9.5 NA
    MIC90 >4/76 4/76 4/76 >4/76 2/38 2/38 NA 2/38 2/38 ≤0.5/9.5 NA
LZD (16)
    MIC range 2–32 1–16 2–16 2–16 ≤1-8 ≤1–4 2-8 ≤1–2 ≤1–2 ≤1 ≤1
    MIC50 16 8 8 4 2 2 2 ≤1 2 ≤1 NA
    MIC90 32 16 8 16 4 4 NA 2 4 ≤1 NA
IPM (8–16)
    MIC range 4 to >32 8 to >32 4–32 8–32 ≤2–8 ≤2–8 ≤2–8 ≤2 to >8 ≤2–4 ≤2–8 ≤2
    MIC50 8 16 16 16 ≤2 ≤2 ≤2 4 4 4 NA
    MIC90 32 >32 16 32 8 8 NA 8 4 8 NA
DOX (2–4)
    MIC range >8 2 to >8 ≤0.12 to >8 4 to >8 ≤0.12 to >8 ≤0.12 to >8 0.25 to >8 2–8 ≤0.12 ≤0.12 to >8 ≤0.12
    MIC50 >8 >8 >8 >8 4 ≤0.12 8 4 ≤0.12 ≤0.12 NA
    MIC90 >8 >8 >8 >8 >8 >8 NA 8 ≤0.12 >8 NA
MIN (2–4)
    MIC range >8 >8 ≤1 to >8 >8 ≤1 to >8 ≤1 to >8 ≤1 to >8 4 to >8 ≤1 ≤1 to >8 ≤1
    MIC50 >8 >8 >8 >8 >8 ≤1 ≤1 4 ≤1 ≤1 NA
    MIC90 >8 >8 >8 >8 >8 >8 NA >8 ≤1 >8 NA
TGC (NA)d
    MIC range 0.06–0.5 0.06–0.25 ≤0.03–0.12 ≤0.03–0.12 ≤0.03–0.06 ≤0.03–0.06 ≤0.03 ≤0.03 ≤0.03 ≤0.03–0.25 ≤0.03
    MIC50 0.12 0.12 0.06 0.12 ≤0.03 ≤0.03 ≤0.03 ≤0.03 ≤0.03 0.06 NA
    MIC90 0.25 0.25 0.12 0.12 0.06 0.06 NA ≤0.03 ≤0.03 0.25 NA
CLR (4)
    MIC range ≤2 to >16 ≤2 to >16 ≤2 ≤2 ≥16 ≥16 ≥16 ≥16 1-≤2 ≤2 8
    MIC50 ≥16 ≤2 ≤2 ≤2 ≥16 >16 ≥16 >16 ≤2 ≤2 NA
    MIC90 ≥16 ≥16g ≤2 ≤2 ≥16 >16 NA >16 ≤2 ≤2 NA
TOB (4)
    MIC range NA NA ≤2 4 to >8 NA NA NA NA NA NA NA
    MIC50 NA NA ≤2 >8 NA NA NA NA NA NA NA
    MIC90 NA NA ≤2 >8 NA NA NA NA NA NA NA
a

NA = not applicable.

b

DEL, delafloxacin; AMK, amikacin; FOX, cefoxitin; SXT, trimethoprim sulfamethoxazole; LZD, linezolid; CIP, ciprofloxacin; IPM, imipenem; MXF, moxifloxacin; DOX, doxycycline; MIN, minocycline; TGC, tigecycline; CLR, clarithromycin; TOB, tobramycin.

c

There are no intermediate breakpoints for SXT; the resistance breakpoint is >64 μg/ml.

d

The CLSI has not addressed breakpoints for tigecycline (TGC) or delafloxacin (DEL).

e

MIC90 values were not calculated for groups with <5 isolates.

f

Four isolates were known to be quinolone resistant.

g

Isolate was mutationally macrolide resistant.